Alport Research Hub Symposium: From Bench to Bedside
Discover key insights from the third Alport Research Hub Symposium and learn how Medpace's expertise advances rare nephrology research.
Behind the Breakthroughs: Rare Disease Q&A with Lauren Shannon
In this Q&A, Lauren Shannon discusses her experience and the role that Medpace plays in advancing innovative rare disease therapies.
Advancing Gene Therapy Innovation in Ophthalmology Trials
Ophthalmic gene therapy clinical trials aim to correct or replace genes in the eye to slow, halt, or reverse inherited...
Expert Perspectives on the Transforming Diabetes Clinical Trial Landscape
As innovation accelerates across diabetes and endocrinology – particularly in areas like type 1 and type 2 diabetes, cell and...
Raising the Standard in Pediatric Migraine Clinical Trials
Featuring: Dr. Sonia Quintas, MD, MSc, Theresa Veira, MSN, MBA, and Pora Kuperman, MPH, PhD Migraine is a leading cause...
Key Highlights from Digestive Disease Week 2026
Digestive Disease Week® 2026 reinforced its position as one of the leading global forums in gastroenterology, bringing together clinicians, researchers,...
ASN Kidney Week: Transformative Nephrology Insights
In this blog, Dr. Ajay Srivastava, Vice President, Medical Department, reflects on these key takeaways from 2025 ASN Kidney Week...
What’s Next for ID&V? Clinical Development Trends from ESCMID Global 2026
Explore several of the key themes emerging from ESCMID Global 2026.
Advancing Psychiatry Clinical Development Through Science, Precision, and Human-Centered Design
Mental health disorders affect an estimated one billion people worldwide, contributing to profound personal, social, and economic burden. As the World Health Organization notes, most…
Inside AD/PD 2026: Emerging Breakthroughs in Alzheimer’s and Parkinson’s
Authors: Carmen Gasca-Salas, MD, MSc, PhD, Medical Director, Medpace Recently, the Medpace neuroscience team attended the AD/PD (Alzheimer’s & Parkinson’s Disease)...